Literature DB >> 2854205

Octopamine relaxes rabbit jejunal smooth muscle by selective activation of dopamine D1 receptors.

J T Cheng1, S C Hsieh-Chen.   

Abstract

The effect of octopamine on intestinal smooth muscle of rabbit isolated jejunum has been studied. Octopamine induced a dose-dependent decrease of muscle tone and this reproducible relaxation was not modified by tetrodotoxin or by agents that acted on adrenergic nerve terminals. Adrenoceptor antagonists, at concentrations sufficient to block each adrenoceptor type, did not reduce the actions of octopamine. On the other hand, octopamine-induced relaxations were affected by agents that have the ability to change cyclic AMP (cAMP) content; such as alloxan (an adenylate cyclase inhibitor), imidazole (a stimulator of phosphodiesterase), and isobutyl methylxanthine (an inhibitor of phosphodiesterase). Direct stimulation of adenylate cyclase by octopamine was demonstrated using radioimmunoassay of cAMP. Furthermore, haloperidol and perphenazine at concentration required to block dopamine receptor sites attenuated both smooth muscle relaxation and the formation of cAMP induced by octopamine. The effect of octopamine was totally blocked by SCH 23390, an antagonist of dopamine D-1 receptors. The lack of effect of domperidone and sulpiride, antagonists of dopamine D-2 receptors, on the actions of octopamine excludes the involvement of dopamine D-2 receptors. These results suggest that octopamine acts on intestinal dopamine D-1 receptor sites to produce relaxation of rabbit jejunum through an increase of cAMP.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2854205     DOI: 10.1007/bf00172112

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  33 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  Deficient production of tyramine and octopamine in cases of depression.

Authors:  M Sandler; C R Ruthven; B L Goodwin; G P Reynolds; V A Rao; A Coppen
Journal:  Nature       Date:  1979-03-22       Impact factor: 49.962

3.  Radioimmunoassay for cyclic nucleotides. II. Adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in mammalian tissues and body fluids.

Authors:  A L Steiner; A S Pagliara; L R Chase; D M Kipnis
Journal:  J Biol Chem       Date:  1972-02-25       Impact factor: 5.157

4.  Studies on the intestinal relaxation produced by dopamine.

Authors:  R D Heilman; B K Lum
Journal:  J Pharmacol Exp Ther       Date:  1971-07       Impact factor: 4.030

5.  Inhibitory effects of alloxan on mammalian adenyl cyclase.

Authors:  K L Cohen; M W Bitensky
Journal:  J Pharmacol Exp Ther       Date:  1969-09       Impact factor: 4.030

6.  Some cardiovascular studies on octopamine.

Authors:  B Korol; L Soffer; M L Brown
Journal:  Arch Int Pharmacodyn Ther       Date:  1968-02

7.  Interactions of guanethidine and indirect-acting sympathomimetic amines.

Authors:  K Starke
Journal:  Arch Int Pharmacodyn Ther       Date:  1972-02

Review 8.  Role of cyclic nucleotides in excitable cells.

Authors:  I Kupfermann
Journal:  Annu Rev Physiol       Date:  1980       Impact factor: 19.318

Review 9.  Octopamine.

Authors:  J Axelrod; J M Saavedra
Journal:  Nature       Date:  1977-02-10       Impact factor: 49.962

10.  Characterization of the release of neuropeptide Y (NPY) induced by tyramine from synaptosomal preparations of rabbit jejunum.

Authors:  J T Cheng; Y H Tuan; C L Shen
Journal:  Eur J Pharmacol       Date:  1987-04-07       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.